CX-213

N/A

Report date: 2025/11/10 17:51:47

NME

Base Information

Drug NameCX-213

Drug Alias NameCeriopolymexCX213CX-213

ClassificationOther

Mechanisms of ActionReactive oxygen species inhibitors

TargetsReactive oxygen species

Therapy Area/IndicationsSubarachnoid Hemorrhage

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesCenyx Biotech Inc

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsSubarachnoid Hemorrhage

Inactive IndicationsN/A

ATC CodeN/A